Since lathosterol levels are known to be increased in the CSF of MS patients [21] but decreased in the plasma [22], elevated PLTP activity in the plasma could also explain the decreased levels of HDL-C reported in MS [23] since plasma HDL-C levels are inversely associated with PLTP activity [24]. This evidence concerns the gene PLTP and myeloid sarcoma.